5.755USD-1.62%Mkt Cap: 79.92M USDP/E: —Last update: 2026-06-01
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides pe…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap79.92M USD
Enterprise Value79.00M USD
Revenue (TTM)57.95M USD
Gross Profit28.55M USD
Net Income (TTM)4.70M USD
Revenue/Share4.199 USD
Last Price5.755 USD
Fiscal Year EndApr 2025
MR QuarterJan 2026
Employees213
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS15870P3073
Valuation
P/E (Trailing)—
P/E (Forward)58.35
PEG—
EV/EBITDA-102.33
EV/Revenue1.36
P/S1.40
P/B18.94
EPS (TTM)-0.18
EPS (Forward)0.10
52W Range
5.5006% of range9.630
52W High9.630 USD
52W Low5.500 USD
Profitability
Gross Margin50.15%
Oper. Margin-1.13%
EBITDA Margin-1.33%
Profit Margin8.26%
ROE124.63%
ROA14.53%
Growth
Revenue Growth-2.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.39M USD
CapEx (TTM)389.00K USD
FCF Margin8.12%
FCF Yield5.88%
Net Debt-2.13M USD
Net Debt/EBITDA2.76
Balance Sheet
Debt/Equity1.62
Current Ratio0.98
Quick Ratio0.93
Book Value/Sh0.3080 USD
Cash/Share0.5130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateAug 12, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.89M
Float5.19M
Insiders26.67%
Institutions47.75%
Short Interest
Short Ratio9.7d
Short % Float1.25%
Short % Out.0.61%
Shares Short84.73K
Short (prev mo.)81.98K
Technical
SMA 505.950 (-3.3%)
SMA 2006.458 (-10.9%)
Beta0.43
S&P 52W Chg27.94%
Avg Vol (30d)10.11K
Avg Vol (10d)11.54K
Technical Indicators
RSI (14)44.6
MACD-0.0220
MACD Signal0.0068
MACD Hist.-0.0287
BB Upper6.234 USD
BB Middle6.007 USD
BB Lower5.780 USD
BB Width7.57%
ATR (14)0.2376 USD
Vol Ratio (20d)1.08x